Pieris Pharmaceuticals, Inc. (PIRS)
NASDAQ: PIRS · IEX Real-Time Price · USD
11.88
-0.16 (-1.33%)
At close: Apr 24, 2024, 3:59 PM
11.62
-0.26 (-2.19%)
After-hours: Apr 24, 2024, 7:52 PM EDT
Pieris Pharmaceuticals Market Cap
Pieris Pharmaceuticals has a market cap or net worth of $14.75 million as of April 24, 2024. Its market cap has decreased by -76.01% in one year.
Market Cap
14.75M
Enterprise Value
-11.61M
1-Year Change
-76.01%
Ranking
Category
Stock Price
$11.88
Market Cap Chart
Since December 31, 2014, Pieris Pharmaceuticals's market cap has decreased from $76.50M to $14.75M, a decrease of -80.71%. That is a compound annual growth rate of -16.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 14.80M | 2.78% |
Apr 22, 2024 | 14.40M | 0.70% |
Apr 19, 2024 | 14.30M | -6.54% |
Apr 18, 2024 | 15.30M | -1.29% |
Apr 17, 2024 | 15.50M | -4.32% |
Apr 16, 2024 | 16.20M | -3.57% |
Apr 15, 2024 | 16.80M | -1.18% |
Apr 12, 2024 | 17.00M | -2.30% |
Apr 11, 2024 | 17.40M | -0.57% |
Apr 10, 2024 | 17.50M | -2.78% |
Apr 9, 2024 | 18.00M | 5.26% |
Apr 8, 2024 | 17.10M | 0.59% |
Apr 5, 2024 | 17.00M | - |
Apr 4, 2024 | 17.00M | -1.16% |
Apr 3, 2024 | 17.20M | -2.27% |
Apr 2, 2024 | 17.60M | -4.86% |
Apr 1, 2024 | 18.50M | 2.21% |
Mar 28, 2024 | 18.10M | -5.24% |
Mar 27, 2024 | 19.10M | 2.69% |
Mar 26, 2024 | 18.60M | 3.33% |
Mar 25, 2024 | 18.00M | -9.09% |
Mar 22, 2024 | 19.80M | - |
Mar 21, 2024 | 19.80M | -4.81% |
Mar 20, 2024 | 20.80M | -2.35% |
Mar 19, 2024 | 21.30M | 2.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Verona Pharma | 1.25B |
Kiniksa Pharmaceuticals | 1.25B |
Pacira BioSciences | 1.25B |
Spyre Therapeutics | 1.24B |
Ligand Pharmaceuticals | 1.24B |
Deciphera Pharmaceuticals | 1.19B |
Scholar Rock Holding | 1.18B |
AbCellera Biologics | 1.16B |